Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MiroBio
Biotech
Gilead makes $405M buy to compete with Lilly's BTLA program
Gilead is snapping up MiroBio for $405M cash, gaining full access to the biotech's BTLA and PD-1 autoimmune programs.
Gabrielle Masson
Aug 4, 2022 11:46am
Oxford Science Enterprises clinches £250M for new startups
Jul 18, 2022 11:26am
Chasing Lilly, MiroBio raises $97M for autoimmune checkpoint R&D
Jun 29, 2022 3:00am
Novartis loses cell, gene leader, digital exec—Chutes & Ladders
Sep 24, 2021 9:30am
Novartis veteran Barth takes the helm at MiroBio
Sep 21, 2021 6:30am
